Коды статистики организации по инн: Коды Росстата. Узнать коды статистики по ИНН или ОГРН. Получить коды статистики онлайн и распечатать Уведомление.

Узнать ОКВЭД по ИНН/ОГРН организации онлайн за 1 минуту

Политика конфиденциальности (далее – Политика) разработана в соответствии с Федеральным законом от 27.07.2006. №152-ФЗ «О персональных данных» (далее – ФЗ-152). Настоящая Политика определяет порядок обработки персональных данных и меры по обеспечению безопасности персональных данных в сервисе vipiska-nalog.com(далее – Оператор) с целью защиты прав и свобод человека и гражданина при обработке его персональных данных, в том числе защиты прав на неприкосновенность частной жизни, личную и семейную тайну. В соответствии с законом, сервис vipiska-nalog.com несет информационный характер и не обязывает посетителя к платежам и прочим действиям без его согласия. Сбор данных необходим исключительно для связи с посетителем по его желанию и информировании об услугах сервиса vipiska-nalog.com.

Основные положения нашей политики конфиденциальности могут быть сформулированы следующим образом:

Мы не передаем Ваши персональную информацию третьим лицам. Мы не передаем Вашу контактную информацию в отдел продаж без Вашего на то согласия. Вы самостоятельно определяете объем раскрываемой персональной информации.

Собираемая информация

Мы собираем персональную информацию, которую Вы сознательно согласились раскрыть нам, для получения подробной информации об услугах компании. Персональная информация попадает к нам путем заполнения анкеты на сайте vipiska-nalog.com. Для того, чтобы получить подробную информацию об услугах, стоимости и видах оплат, Вам необходимо предоставить нам свой адрес электронной почты, имя (настоящее или вымышленное) и номер телефона. Эта информация предоставляется Вами добровольно и ее достоверность мы никак не проверяем.

Использование полученной информации

Информация, предоставляемая Вами при заполнении анкеты, обрабатывается только в момент запроса и не сохраняется. Мы используем эту информацию только для отправки Вам той информации, на которую Вы подписывались.

Предоставление информации третьим лицам

Мы очень серьезно относимся к защите Вашей частной жизни. Мы никогда не предоставим Вашу личную информацию третьим лицам, кроме случаев, когда это прямо может требовать Российское зак

Коды статистики по ИНН

При регистрации частного предприятия, будь то общество с ограниченной ответственностью или индивидуальный предприниматель, директору предстоит узнать, что такое коды статистики.

Это определенные числа, персональные для каждого субъекта. Их значения хранятся в государственной базе данных и отражают сведения о предприятии. Коды статистики по ИНН находят применения в различных сферах. Они помогут открыть банковский счет для новой организации, оформить изменения, связанные со сменой руководителя фирмы, сменить регион, в котором зарегистрировано предприятие, будут полезны при сдаче бухгалтерской, налоговой, статистической отчетности, а также при проведении операций импорта и экспорта различных товаров.

Если при оформлении нового субъекта Вы не узнали коды, исправить это можно с применением нескольких методов. Одним из них может быть отправка специального запроса в налоговую службу. Кроме этого, есть возможность выяснить коды статистики по ИНН онлайн на официальном веб-ресурсе Федеральной службы государственной статистики Росстат. Это очень удобно, так как не придется посещать территориальный орган службы. Информация по установлению кодов размещена в открытом доступе. Обновление базы проводится два-три раза в месяц.

Чтобы выяснить коды с использованием онлайн-сервиса на официальном сайте Росстата следует нажать на «Уведомления о кодах по общероссийским классификаторам», а затем кликнуть по предлагаемой ссылке.

Сервис на Росстате

Далее необходимо сформировать уведомление. Для этого потребуется указать относитесь Вы к юридическим лицам или к индивидуальным предпринимателям. На этой странице также можно ознакомиться с контактами и адресами территориальных органов в выбранной области, а также с их официальными сайтами.

Переход к оформлению запроса

Перейдя по соответствующей ссылке, можно увидеть информацию о том, какие конкретно коды можно выяснить, отправив запрос, как правильно его сформировать и сохранить для последующей печати.

Чтобы отправить уведомление, следует выбрать его тип (для юридических лиц; для филиалов, представительств, организаций, осуществляющих свою деятельность без образования юридического лица; для индивидуальных предпринимателей, глав крестьянских или фермерских хозяйств; для адвокатов и частных нотариусов). Следующим шагом станет заполнение одного из реквизитов. Это, в основном, ОКПО, ИНН или ОГРНИП. В завершении остается ввести контрольный код и нажать кнопку «Поиск».

Формирование уведомления

Затем на экране отразятся результаты поиска. Для интересуемого субъекта дается возможность скачать перечень форм и коды ОК ТЭИ в виде уведомления. Среди кодов в документе отражены классификация по ОКАТО (Общероссийский классификатор объектов административно-территориального деления), ОКТМО (общероссийский классификатор территорий муниципальных образований), ОКОГУ (общероссийский классификатор органов государственной власти и управления), ОКФС (общероссийский классификатор форм собственности), ОКОПФ (общероссийский классификатор организационно-правовых форм), а также расшифровка кодов ОК ТЭИ, характеризующих отрасль, к которой относится предприятие, регион, в котором располагается, форму собственности.

Уведомление

Кроме официального интернет-ресурса Федеральной службы коды статистики по ИНН можно узнать, воспользовавшись ресурсом кодыросстата.рф. Для этого способа необходимо сперва указать область, в которой зарегистрировано предприятие, а далее составить уведомление по описанной выше методике.

Выбор региона

Иногда случаются ситуации, когда уведомлением нужно срочно воспользоваться, а таких сведений в базе еще нет. Тогда Вам лично потребуется посетить территориальный орган, относящийся к месту регистрации фирмы. При этом на руках необходимо иметь выписку из ЕГРЮЛ или ЕГРИП.

Полученные на сайте Росстата коды статистики по ИНН можно использовать в напечатанном виде. Они несут информационную и справочную функцию, тем самым не требуя заверения печатью или подписи должностного лица.

Кроме этого, Федеральная служба на своем официальном интернет-ресурсе предоставляет общую информацию о наиболее часто используемых классификаторах. К ним относятся ОКВЭД (общероссийский классификатор видов экономической деятельности), ОКПД (Общероссийский классификатор продукции по видам экономической деятельности), КИЕС (Классификатор институциональных единиц по секторам экономики). Здесь ознакомлению предоставляются библиографические данные о них, последние вводимые изменения и прочие документы.

Сведения о кодах статистики

Коды статистики по ИНН являются обязательными для всех организаций и предприятий, действующих на территории России. Без них руководство не сможет выполнить определенные операции, а также возникнут сложности в бухгалтерской и статистической отчетности.

90000 WHO | International Nonproprietary Names 90001 90002 90003 Essential medicines and health products 90004 90005 90006 Guidance 90007 90002 International Nonproprietary Names (INN) facilitate the identification of pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property.A nonproprietary name is also known as a generic name. 90005 90006 Mandate 90007 90002 WHO has a constitutional mandate to 90013 90014 «develop, establish and promote international standards with respect to biological, pharmaceutical and similar products». 90002 The World Health Organization collaborates closely with INN experts and national nomenclature committees to select a single name of worldwide acceptability for each active substance that is to be marketed as a pharmaceutical.To avoid confusion, which could jeopardize the safety of patients, trade-marks should neither be derived from INNs nor contain common stems used in INNs. 90016 90017 The selection and publication of INNs falls under the responsibility of the EMP / RHT / TSN team of the INN Programme. 90005 90005 90006 90013 90014 Information 90007 90006 90013 90014 Requesting an INN 90007 90028 Selection process of INNs 90029 90028 To apply for a new INN, please use the online application form 90029 90028 To select an appropriate stem 90029 90006 90013 90014 Published INN Lists 90007 90006 90013 90014 INN and Biologicals 90007 90006 90013 90014 All INN publications 90007 90006 90013 90014 Online access to INN data 90007 90006 Enquiries 90007 90002 For information on INN, please contact the innprogramme @ who.int 90005 90002 Dr R. Balocco Mattavelli 90055 World Health Organization 90055 1211 Geneva 27 90 055 Switzerland 90055 Fax: +41 22 791 4856/5853 90005 90006 LATEST NEWS 90007 90006 71 90063 st 90064 INN consultation 90007 90002 The 71 90063 st 90064 Consultation on International Nonproprietary Names (INN) for Pharmaceutical Substances will take place from: 90055 20-23 October 2020. 90005 90002 90013 Deadlines for submissions: 90014 90055 90013 New INN requests 90055 90077 Friday, 31 90063 st 90064 July 2020.90080 90014 90055 Early submissions are encouraged and welcome. 90055 90013 Outstanding INN requests 90055 90077 Friday, 7 90063 th 90064 August 2020. 90080 90014 90055 90005 90006 90002 COVID-19 medicinal substances 90016 ad hoc 90017 INN meeting — 70th INN Consultation Addendum — 90005 90007 90002 90002 The ad hoc meeting will be held on 20-21 August 2020 90055 (Deadline 90077 Friday, 31 90063 st 90064 July 2020) 90080 90005 90005 90006 Countdown requests for 71st INN Consultation: 90077 30 90080 request available! 90007 90002 The counter for new requests will start on June 30th 2020.90005 90006 Training course on INN (to be confirmed) 90007 90002 Deadline for Expression of Interest (EOI) to be confirmed 90005 90006 INN Session with INN stakeholders -BY WEBEX ONLY- (on 20 90063 th 90064 October 2020) 90007 90002 Deadline for Expression of Interest (EOI), LoP and presentations on 11 90063 th 90064 September 2020 90005 .90000 WHO | Guidance on INN 90001 printable version 90002 90003 Introduction 90004 90005 90006 90007 90008 90009 90010 90011 International Nonproprietary Names (INN) identify pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. 90012 Guidelines on the Use of INNs for Pharmaceutical Substances (1997) 90011 The INN system as it exists today was initiated in 1950 by a World Health Assembly resolution WHA3.11 and began operating in 1953 when the first list of International Nonproprietary Names for pharmaceutical substances was published. The cumulative list of INN now stands at some 7000 names designated since that time, and this number is growing every year by some 120-150 new INN. 90012 90011 Since its inception, the aim of the INN system has been to provide health professionals with a unique and universally available designated name to identify each pharmaceutical substance. The existence of an international nomenclature for pharmaceutical substances, in the form of INN, is important for the clear identification, safe prescription and dispensing of medicines to patients, and for communication and exchange of information among health professionals and scientists worldwide.90012 90011 As unique names, INN have to be distinctive in sound and spelling, and should not be liable to confusion with other names in common use. To make INN universally available they are formally placed by WHO in the public domain, hence their designation as «nonproprietary». They can be used without any restriction whatsoever to identify pharmaceutical substances. 90012 90011 Another important feature of the INN system is that the names of pharmacologically-related substances demonstrate their relationship by using a common «stem».By the use of common stems the medical practitioner, the pharmacist, or anyone dealing with pharmaceutical products can recognize that the substance belongs to a group of substances having similar pharmacological activity. 90012 90011 The extent of INN utilization is expanding with the increase in the number of names. Its wide application and global recognition are also due to close collaboration in the process of INN selection with numerous national drug nomenclature bodies. The increasing coverage of the drug-name area by INN has led to the situation whereby the majority of pharmaceutical substances used today in medical practice are designated by an INN.The use of INN is already common in research and clinical documentation, while their importance is growing further due to expanding use of generic names for pharmaceutical products. 90012 90003 Use of INN 90004 90011 Nonproprietary names are intended for use in pharmacopoeias, labelling, product information, advertising and other promotional material, drug regulation and scientific literature, and as a basis for product names, e.g. for generics. Their use is normally required by national or, as in the case of the European Community, by international legislation.As a result of ongoing collaboration, national names such as British Approved Names (BAN), Dénominations Communes Françaises (DCF), Japanese Adopted Names (JAN) and United States Accepted Names (USAN) are nowadays, with rare exceptions, identical to the INN . 90012 90011 Some countries have defined the minimum size of characters in which the generic nonproprietary name must be printed under the trade-mark labelling and advertising. In several countries the generic name must appear prominently in type at least half the size of that used for the proprietary or brand-name.In some countries it has to appear larger than the trade-mark name. Certain countries have even gone so far as to abolish trade-marks within the public sector. 90012 90011 To avoid confusion, which could jeopardize the safety of patients, trade-marks can not be derived from INN and, in particular, must not include their common stems. As already mentioned the selection of further names within a series will be seriously hindered by the use of a common stem in a brand-name. 90012 90003 Selection of INN 90004 90011 The names which are given the status of an INN are selected by the World Health Organization on the advice of experts from the WHO Expert Advisory Panel on the International Pharmacopoeia and Pharmaceutical Preparations.The process of INN selection follows three main steps: 90012 90011 — a request / application is made by the manufacturer or inventor; — after a review of the request a proposed INN is selected and published for comments; — after a time-period for objections has lapsed, the name will obtain the status of a recommended INN and will be published as such if no objection has been raised. 90012 90011 INN are selected in principle only for single, well-defined substances that can be unequivocally characterized by a chemical name (or formula).It is the policy of the INN programme not to select names for mixtures of substances, while substances that are not fully characterized are included in the INN system in exceptional cases only. INN are not selected for herbal substances (vegetable drugs) or for homoeopathic products. It is also the policy of the INN programme not to select names for those substances that have a long history of use for medical purposes under well-established names such as those of alkaloids (e.g. morphine, codeine), or trivial chemical names (e.g. acetic acid). 90012 90011 An INN is usually designated for the active part of the molecule only, to avoid the multiplication of entries in cases where several salts, esters, etc. are actually used. In such cases, the user of the INN has to create a modified INN (INNM) himself; mepyramine maleate (a salt of mepyramine with maleic acid) is an example of an INNM. When the creation of an INNM would require the use of a long or inconvenient name for the radical part of the INNM, the INN programme will select a short name for such a radical (for example, mesilate for methanesulfonate).90012 90011 In the process of INN selection, the rights of existing trade-mark owners are fully protected. If in the period of four months following the publication of a proposed INN, a formal objection is filed by an interested person who considers that the proposed INN is in conflict with an existing trade-mark, WHO will actively pursue an arrangement to obtain a withdrawal of such an objection or will reconsider the proposed name. As long as the objection exists, WHO will not publish it as a recommended INN.90012 90011 The selection of a new INN relies on a strict procedure. Upon receipt of an INN request form, the WHO Secretariat examines the suggested names for conformity with the general rules, for similarities with published INN and potential conflicts with existing names, including published INN and trade-marks. A note summarizing the result of these checks is added and the request is subsequently forwarded to the INN experts for comments. Once all experts agree upon one name, the applicant is informed of the selected name.90012 90011 Newly selected, proposed INN are then published in WHO Drug Information, which indicates a deadline for a 4-month objection period. This period is allowed for comments and / or objections to the published names to be raised. The reasons for any objection must be stated clearly and these will be evaluated by the experts for further action. Users are invited to refrain from using the proposed name until it becomes a recommended INN, in order to avoid confusion should the name be modified.Two lists of proposed INN are published yearly. 90012 90011 The final stage of the selection process is the recommended INN. Once a name has been published as a recommended INN it will not normally be modified further and is ready for use in labelling, publications, on drug information. It will serve to identify the active pharmaceutical substance during its life-time worldwide. Since the name is available in the public domain it may be used freely. However, it should not be registered as a trade-mark since this would prevent its use by other parties.90012 90011 Recommended INN are published in the WHO Drug Information as a consequence of the objection procedure applied to proposed INN. As from 1997, two lists of proposed INN are published yearly and as from list 37 of recommended INN, graphic formulae are also included for better identification of the substances. 90012 90011 The procedure for selecting recommended INN is carried out in accordance with a text adopted by the WHO Executive Board. 90012 90003 Names for radicals and groups 90004 90011 Names for radicals and groups During the 1975 meeting on Nonproprietary Names for Pharmaceutical Substances the experts discussed the issue of INN for salts and esters and noted that requests had frequently been received for INN for salts, esters, or combination products of substances for which INN already existed.At that time, the experts decided that INN for the simple salt and esters should be devised from the INN in conformity with normal chemical practice. 90012 90011 Some of the radicals and groups involved are, however, of such complex composition that it makes it inconvenient to use the chemical nomenclature. It was thus decided that in such cases, shorter nonproprietary names are selected for these inactive moieties and published in proposed lists under the title «Names for Radicals and Groups».Separate names for salts and esters derived from this procedure are not published. If a «radical and group name» is used in conjunction with an INN, they are referred to as International Nonproprietary Name (Modified) or INNM. 90012 90011 A comprehensive list of radicals and groups may be obtained from WHO’s Marketing and Dissemination unit (INNs: Names for radicals and groups, combined summary list). 90012 90003 Modified INN (INNM) 90004 90011 In principle, INN are selected only for the active part of the molecule which is usually the base, acid or alcohol.In some cases, however, the active molecules need to be expanded for various reasons, such as formulation purposes, bioavailability or absorption rate. In один тисячі дев’ятсот сімдесят п’ять the experts designated for the selection of INN decided to adopt a new policy for naming such molecules. In future, names for different salts or esters of the same active substance should differ only with regard to the inactive moiety of the molecule. For example, oxacillin and ibufenac are INN and their salts are named oxacillin sodium and ibufenac sodium.The latter are called modified INN (INNM). 90012 90011 Before the existence of this rule, some INN were published for salts. In such cases, the term «modified INN» may also be used for a base or acid. For example, levothyroxine sodium was published as an INN and levothyroxine may thus be referred to as an INNM. 90012 90003 Protection of INN 90004 90011 Lists of both proposed and recommended INN are sent by WHO, together with a note verbale, to the Organization’s Member States (at present 191), to national pharmacopoeia commissions and to other bodies designated by Member States.In his note verbale, the Director-General of the World Health Organization requests that Member States should take such steps as are necessary to prevent the acquisition of proprietary rights on the name, including prohibiting registration of the name as a trade name. 90012 90011 Over the years, the need to maintain the integrity of the INN system has become urgent. This is reflected in the following extract from the Fifth Report of the WHO Expert Committee on the Use of Essential Drugs which met in November 1991: 90012 90011 «The procedure for selecting INNs allows manufacturers to contest names that are either identical or similar to their licensed trade-marks.In contrast, trade-mark applications are disallowed, in accordance with the present procedure, only when they are identical to an INN. A case for increased protection of INNs is now apparent as a result of competitive promotion of products no longer protected by patents. Rather than marketing these products under generic name, many companies apply for a trade-mark derived from an INN and, in particular, including the INN common stem. This practice endangers the principle that INNs are public property; it can frustrate the rational selection of further INNs for related substances, and it will ultimately compromise the safety of patients by promoting confusion in drug nomenclature.»90012 90011 These concerns were debated during the sixth International Conference of Drug Regulatory Authorities (ICDRA), in Ottawa, in October 1991. Based on recommendations made by the WHO Expert Committee on the use of Essential Drugs, the resolution WHA46.19 on Nonproprietary names for pharmaceutical substances was adopted by the Forty-sixth World Health Assembly in 1993, requesting Member States to: 90012 90011 — «… enact rules or regulations, as necessary, to ensure that international nonproprietary names (or the equivalent nationally approved generic names) used in the labelling and advertising of pharmaceutical products are always displayed prominently; — … encourage manufacturers to rely on their corporate name and the international nonproprietary names, rather than on trade-marks, to promote and market multisource products introduced after the expiry of a patent; — … develop policy guidelines on the use and protection of international nonproprietary names, and to discourage the use of names derived from them, and particularly names including established stems, as trade-marks.»90012 90011 In the note verbale, attention is drawn to this resolution concerning the use and protection of INN. 90012 90011 As a matter of principle, it may thus be recommended that trade-marks should not be derived from INN. In particular, the intentional incorporation of meaningful INN stems in trade-marks should be avoided. 90012 90011 Similarly, inclusion of elements from biochemical nomenclature (like? Feron from interferon, or? Leukin from interleukin) in trade marks in anticipation is discouraged since these elements are likely to be utilized as stems within the INN nomenclature.Their inclusion in trade-marks could pre-empt the logical development of the INN nomenclature. 90012 90011 In accordance with resolution WHA46.19, registration of an INN together with a firm’s name is perfectly acceptable, as long as it does not prevent another manufacturer from using the same approach. 90012 90003 RELATED LINKS 90004 :: Guidelines on the Use of INNs for Pharmaceutical Substances (1997) .90000 International Nonproprietary Names (INN) — Drugs.com 90001 90002 International Nonproprietary Names (INN) identify pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name. The INN system is managed by the World Health Organization (WHO). 90003 90004 History of the International Nonproprietary Names System 90005 90002 The INN system was established in 1950 by the World Health Assembly and the first list of International Nonproprietary Names for pharmaceutical substances was published in 1953.The cumulative list of INN now stands at some 7000 names designated since that time, and this number is growing every year by some 120-150 new INN. 90003 90002 Since its inception, the aim of the INN system has been to provide health professionals with a unique and universally available designated name to identify each pharmaceutical substance. The existence of an international nomenclature for pharmaceutical substances, in the form of INN, is important for the clear identification, safe prescription and dispensing of medicines to patients, and for communication and exchange of information among health professionals and scientists worldwide.90003 90002 As unique names, INN have to be distinctive in sound and spelling, and should not be liable to confusion with other names in common use. To make INN universally available they are formally placed by WHO in the public domain, hence their designation as «nonproprietary». They can be used without any restriction whatsoever to identify pharmaceutical substances. 90003 90002 Another important feature of the INN system is that the names of pharmacologically-related substances demonstrate their relationship by using a common «stem».By the use of common stems the medical practitioner, the pharmacist, or anyone dealing with pharmaceutical products can recognize that the substance belongs to a group of substances having similar pharmacological activity. 90003 90004 Use of International Nonproprietary Names 90005 90002 Nonproprietary names are intended for use in pharmacopoeias, labeling, product information, advertising and other promotional material, drug regulation and scientific literature, and as a basis for product names, e.g. for generics. 90003 90002 As a result of ongoing collaboration, national names such as British Approved Names (BAN), Dénominations Communes Françaises (DCF), Japanese Adopted Names (JAN) and United States Accepted Names (USAN) are nowadays, with rare exceptions, identical to the INN. These national naming schemes can be country specific. That is, they refer to ingredients used in the particular country with names intended to meaningful to its citizens. As a result, there is significant overlap and yet some differences between various national schemes.For example, differences exist between BAN and USAN names for the same substance (e.g. acetaminophen is also called paracetamol). In addition to having different names for the same substances, different countries permit the use of different medicinal ingredients. It is assured that all US medications do not have approved names under other countries ‘naming schemes. Likewise, these international naming schemes cover medications not currently employed in the USA. 90003 90002 To avoid confusion, which could jeopardize the safety of patients, trade-marks can not be derived from INN and, in particular, must not include their common stems.The creation of further names within a series would be seriously hindered by the use of a common stem in a brand-name. 90003 90004 Modified International Nonproprietary Names (INNM) 90005 90002 In principle, INN are selected only for the active part of the molecule which is usually the base, acid or alcohol. In some cases, however, the active molecules need to be expanded for various reasons, such as formulation purposes, bioavailability or absorption rate. In один тисячі дев’ятсот сімдесят п’ять the experts designated for the selection of INN decided to adopt a new policy for naming such molecules.In future, names for different salts or esters of the same active substance should differ only with regard to the inactive moiety of the molecule. For example, oxacillin and ibufenac are INN and their salts are named oxacillin sodium and ibufenac sodium. The latter are called modified INN (INNM). 90003 90002 Before the existence of this rule, some INN were published for salts. In such cases, the term «modified INN» may also be used for a base or acid. For example, levothyroxine sodium was published as an INN and levothyroxine may thus be referred to as an INNM.90003 90002 Return to the Drugs.com International Drug Name Database. 90003.90000 How do I find my SOC code? 90001 90002 Q. How do I find my Standard Occupational Classification (SOC) code? 90003 90002 A. The Standard Occupational Classification (SOC) Information Desk is often asked to provide coding interpretations. To address questions on how workers are classified, the SOC manual provides guidance in the SOC Classification Principles and Coding Guidelines as referenced below. The principles and guidelines help users of statistical data find occupations based on a specific set of work activities and help statistical data collectors classify workers into occupations.The SOC Information Desk does not provide official classification determinations. Customers and clients of organizations using the SOC should use the SOC Classification Principles and Coding Guidelines to classify workers, or contact the organization requesting the SOC code for assistance. 90003 90002 Under the SOC system, workers are classified into occupations based on their job duties, not their job titles. Workers with the same title may be classified in different occupations, based on their individual job duties.90003 90002 The best way to proceed is to look at the various definitions for the SOC occupations and determine which best matches the work being performed. Starting with the major group level, one can examine more specific groupings at the minor, broad, and detailed levels. Definitions are only available at the detailed occupation level, which is indicated by a code ending in a number other than 0. Workers who do not perform activities described in any distinct detailed occupation are included in an appropriate ( «All Other») occupation.The «All Other» occupations appear as the last occupation in a group and are indicated by a code ending in the number 9. The 2010 SOC major groups are available here and the 2018 SOC major groups are available here. 90003 90002 More information on using the SOC to classify workers can be found in the 2010 SOC Classification Principles and Coding Guidelines and the 2018 SOC Classification Principles and Coding Guidelines. The Classification Principles form the basis on which the SOC system is structured.The Coding Guidelines are intended to assist users in the federal statistical agencies in consistently assigning SOC codes and titles to survey responses and in other coding activities. 90003 90002 Warranting specific mention are Classification Principles 1 and 2, as well as Coding Guideline 2. Focusing on the 2018 SOC, Classification Principle 1 states that «Each occupation is assigned to only one occupational category at the most detailed level of the classification.» Classification Principle 2 states that «Occupations are classified based on work performed and, in some cases, on the skills, education, and / or training needed to perform the work.»Coding Guideline 2 states that» When workers in a single job could be coded in more than one occupation, they should be coded in the occupation that requires the highest level of skill. If there is no measurable difference in skill requirements, workers should be coded in the occupation in which they spend the most time. «90003 90002 Those wishing to use the SOC for nonstatistical purposes should first determine if the SOC meets their needs. Such organizations are not limited to following the SOC Classification Principles and Coding Guidelines used by federal statistical agencies and may, for example, develop their own policies concerning workers that meet the definition of two or more occupations.90003 90002 The SOC was designed solely for statistical purposes. Although it is likely that the SOC also will be used for various nonstatistical purposes (eg, for administrative, regulatory, or taxation functions), the requirements of government agencies or private users that choose to use the SOC for nonstatistical purposes have played no role in its development, nor will the Office of Management and Budget modify the classification to meet the requirements of any nonstatistical program.Consequently, the SOC is not to be used in any administrative, regulatory, or tax program unless the head of the agency administering that program has first determined that the use of such occupational definitions is appropriate to the implementation of the program’s objectives. 90003 90002 Customers seeking information on prevailing wages should contact the Employment and Training Administration, Wage and Hour Division, Office of Foreign Labor Certification. Customers applying for paid family leave in the state of New York should call 844-337-6303 from 8:30 am — 4:30 pm ET, Monday & -Friday for assistance.Customers requiring assistance with codes for wage records in Louisiana should contact [email protected] or 1-888-302-7662. 90003 .